Stock data

保瑞 (6472)

保瑞 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$2.33B, up 35.1% from a year earlier. EPS over the last four quarters totals NT$8.96.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 保瑞 in Insightr